查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2006306

内视镜黏膜下剥离术市场：2026-2032年全球市场预测（依产品类型、手术类型、适应症、疾病及最终用户划分）

Endoscopic Submucosal Dissection Market by Product, Procedure Type, Indication Type, Disease Condition, End-User Type - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 191 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，内视镜黏膜下剥离术 (ESD) 市值将达到 4.366 亿美元，到 2026 年将成长至 4.6196 亿美元，到 2032 年将达到 6.629 亿美元，年复合成长率为 6.14%。

主要市场统计数据
基准年 2025 4.366亿美元
预计年份：2026年 4.6196亿美元
预测年份 2032 6.629亿美元
复合年增长率 (%) 6.14%

内视镜黏膜下剥离术（ESD）作为微创胃肠道介入领域的突破性进展，最初起源于东亚，并逐渐在欧洲和美国普及。此技术能够完整切除黏膜下层的早期肿瘤病变，从而最大限度地减少手术创伤，同时优化组织病理学评估。医学界高度重视ESD无与伦比的精准性，使其成为早期胃肠道癌症和某些癌前病变治疗的重要治疗方法。内视镜成像技术、电外科系统整合以及内视镜操作性的现代进步，共同提高了手术安全性，并拓展了其适应症，使其不再局限于最初的胃癌治疗。

随着技术的日趋成熟，涵盖胃肠病学、外科肿瘤学和生物医学工程等多学科领域的专业知识融合，推动了器械设计和操作者技能的持续改进。如今，领先的医疗中心普遍采用基于模拟的培训模组、导师制专案和结果登记系统，以缩短学习曲线并规范临床通讯协定。这些协作框架加速了ESD在全球的普及，使其从小众创新发展成为先进治疗性内视镜的基石。在此背景下，包括医疗服务提供者、医疗设备製造商和保险报销机构在内的各利益相关人员，仍在不断寻求在临床疗效、降低手术成本和扩大患者就医范围之间取得平衡。

变革性创新、协作培训和以患者为中心的进步正在重新定义流程标准。

内视镜黏膜下剥离术 (ESD) 领域正经历着模式转移，这主要得益于器械和成像技术的不断创新。近年来，刀具技术的改进，例如绝缘刀尖、双刀尖和三角刀尖等设计，显着提高了切除精度，同时降低了黏膜下穿孔的风险。同时，高清内视镜成像与窄频成像和共聚焦雷射内视镜等即时组织分析技术的结合，使临床医生能够以前所未有的精度识别病变边界。此外，人工智慧驱动的决策支援系统也为这些技术进步提供了有力支持，它们能够辅助病变分割和电外科参数优化，从根本上改变了手术流程和治疗效果。

2025 年美国关税调整对医疗设备采购和临床实务的影响。

2025年，美国实施了一系列针对进口医疗设备和内视镜黏膜下剥离术（ESD）关键零件的关税调整。这些调整给整个供应链带来了隐性的成本压力，尤其是在先进的电外科设备、专用供气设备和高解析度内视镜领域。医院和门诊诊所正在考虑调整采购惯例，例如供应商多元化和主动重新谈判合同，以减轻整体成本上升的影响。同时，製造商也在重组供应链，探索近岸外包的机会，并优化零件采购，以保持价格竞争力，确保临床医生能够获得最先进的设备。

基于产品创新、流程变化、临床适应症、病理分类和通路参与的市场区隔策略分析。

内视镜黏膜下剥离术 (ESD) 市场可透过检验辅助设备和核心内视镜系统的产品创新进行分析。辅助设备包括帽罩组件、钳子和夹子、注射针、充气装置、各种刀具亚型和套管针。即使在刀具类别内部，具有双头、柔性头、钩状头、绝缘头和三角形头的器械也针对特定的组织纹理和病变形状进行了性能优化。内视镜系统进一步细分为大肠镜、十二指肠镜和胃镜，每种系统都有其自身的人体工学和光学配置，这些配置会影响手术效率和临床医生的偏好。

这份文件揭示了全球市场的区域采用趋势、偿还框架和创新轨迹。

在美洲，完善的医疗基础设施和成熟的医疗保险报销体系为内视镜黏膜下剥离术（ESD）的广泛应用奠定了坚实的基础。美国和加拿大的顶尖医疗中心在手术量方面处于领先地位，并发表了重要的临床证据，从而增强了相关人员的信心。支持先进内视镜介入治疗的政策环境使保险公司能够认识到微创病变切除术带来的长期成本节约，这反过来又鼓励了更多患者接受治疗，并促进了医疗保健对尖端设备的投入。

构成永续发展教育生态系统的关键相关人员的竞争格局和策略趋势

一群全球医疗技术领导企业和创新专家正在重塑内视镜黏膜下剥离术 (ESD) 市场的竞争格局。成熟的主要企业正透过产品改进不断强化自身实力，为先进的刀型和符合人体工学设计的内视镜获取智慧财产权，并利用全球分销网络扩大市场渗透率。同时，Start-Ups的新创公司正透过推出人工智慧驱动的病变检测软体和旨在简化手术流程的新一代空气充气技术而迅速崛起。

具有前瞻性的策略和协作倡议，以推动创新、市场渗透和永续成长。

为了充分掌握内视镜黏膜下剥离术快速成长的机会，产业领导者必须优先发展跨领域伙伴关係，整合临床、监管和商业方面的专业知识。优先投资研发配备自适应回馈机制的新一代电外科设备，将有助于产品线差异化，并应对不断变化的临床挑战。同时，建立整合虚拟实境模拟器和认证训练计画的综合训练体系，将确保手术品质的一致性，并缩短新兴市场的推广应用週期。

严谨的多模态研究框架，整合了原始调查、二手资料和分析三角测量。

本执行执行摘要依据的研究是透过精心结合一手和二手调查资料而完成的。研究人员与关键意见领袖 (KOL) 和内视镜医师进行了结构化访谈和咨询研讨会，以深入观点内视镜黏膜下剥离术的临床工作流程、技术应用障碍以及未满足的需求。除这些定性研究结果外，研究人员还广泛查阅了同行评审期刊、临床试验註册资料和会议论文集，检验不断发展的最佳实践和新型医疗设备的效能资料。

整合核心洞察与未来展望，为决策者提供支持，并巩固市场领导地位。

本执行摘要阐述了技术创新、不断变化的监管环境以及市场动态之间错综复杂的相互作用，这些因素共同塑造了内视镜黏膜下剥离术 (ESD) 领域。主要结论强调了先进刀具设计、精密成像技术和人工智慧驱动的决策支援工具对手术有效性和安全性的关键影响。同时，费用调整和不断变化的报销环境也要求制定灵活的筹资策略并积极与相关人员沟通。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 市场进入策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 内视镜黏膜下剥离术市场：依产品划分

  • 配件
    • 帽子
    • 镊子和夹子
    • 注射针
    • 供气设备
    • 刀
      • 双重的
      • 弹性
      • 钩
      • 带绝缘尖端
      • 三角形尖端
    • 套管针
  • 内视镜设备
    • 大肠镜检查
    • 十二指肠内视镜检查
    • 胃镜检查

第九章 内视镜黏膜下剥离术市场（依手术类型划分）

  • 全层切除
  • 混合型静电放电
  • 部分厚度切除

第十章：内视镜黏膜下剥离术市场（依适应症划分）

  • 结肠癌
  • 食道癌
  • 胃癌

第十一章 依疾病分类的内视镜黏膜下剥离术市场

  • 良性肿瘤
  • 恶性肿瘤
    • 侵入性
    • 非侵入性

第十二章 内视镜黏膜下剥离术市场（依最终用户划分）

  • 门诊手术中心
  • 医院
  • 专科诊所

第十三章 内视镜黏膜下剥离术市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章 内视镜黏膜下剥离术市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章 内视镜黏膜下剥离术市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国内视镜黏膜下剥离术市场

第十七章：中国内视镜黏膜下剥离术市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Ambu A/S
  • Beijing ZKSK Technology Co., Ltd.
  • Boston Scientific Corporation
  • ConMed Corporation
  • Erbe Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Hoya Corporation
  • Huger Medical Instrument Co., Ltd.
  • Interscope, Inc.
  • Jiangsu Vedkang Medical Science and Technology Co., Ltd.
  • Karl Storz SE & Co. KG
  • Leo Medical Co. Ltd.
  • Medi-Globe GmbH by DCC Healthcare
  • Medtronic PLC
  • Micro-Tech Endoscopy
  • Mizuho America, Inc.
  • MTW-Endoskopie W. Haag KG
  • Olympus Corporation
  • Ovesco Endoscope AG
  • Richard Wolf GmbH
  • SonoScape Medical Corp.
  • Steris Corporation
  • Sumitomo Bakelite Co., Ltd.
  • Zeon Medical Inc.
Product Code: MRR-F611BFBC6402

The Endoscopic Submucosal Dissection Market was valued at USD 436.60 million in 2025 and is projected to grow to USD 461.96 million in 2026, with a CAGR of 6.14%, reaching USD 662.90 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 436.60 million
Estimated Year [2026] USD 461.96 million
Forecast Year [2032] USD 662.90 million
CAGR (%) 6.14%

Endoscopic Submucosal Dissection (ESD) emerged as a groundbreaking advancement in minimally invasive gastrointestinal interventions, initially pioneered in East Asia and progressively embraced by Western markets. This technique offers the capacity to achieve en bloc resection of early-stage neoplastic lesions within the submucosal layer, thereby minimizing procedural invasiveness while optimizing histopathological assessment. The clinical community has recognized ESD for its unparalleled precision, making it indispensable for managing early gastrointestinal cancers and select premalignant conditions. Contemporary enhancements in endoscopic imaging, electrosurgical system integration, and scope maneuverability have collectively elevated procedural safety profiles and expanded therapeutic indications beyond the initial gastric focus.

As the technology matures, a convergence of multidisciplinary expertise spanning gastroenterology, surgical oncology, and biomedical engineering has driven iterative improvements in instrument design and operator competency. Centers of excellence now routinely incorporate simulation-based training modules, proctorship programs, and outcome registries to streamline learning curves and standardize clinical protocols. These collaborative frameworks have accelerated global adoption, enabling ESD to transition from a niche innovation to a cornerstone in advanced therapeutic endoscopy. Against this backdrop, stakeholders across healthcare delivery, device manufacturing, and reimbursement agencies continue to navigate the balance between clinical efficacy, procedural cost containment, and broadening patient access.

Transformative Innovations, Collaborative Training, and Patient-Centered Advances Redefining Procedural Standards

The landscape of Endoscopic Submucosal Dissection is undergoing a paradigm shift driven by relentless innovation in instrumentation and imaging modalities. Recent refinements in knife technology, including insulation-tipped, dual, and triangle-tipped designs, have significantly enhanced resection precision while mitigating the risk of submucosal perforation. Simultaneously, the integration of high-definition endoscopic visualization and real-time tissue characterization through narrow-band imaging and confocal laser endomicroscopy has empowered clinicians to delineate lesion boundaries with unprecedented accuracy. These technological leaps are complemented by AI-enabled decision support systems that assist in lesion segmentation and electrosurgical parameter optimization, fundamentally altering procedural workflows and outcomes.

Equally transformative are the evolving training paradigms that prioritize competency-based progression and simulation-driven skill acquisition. Virtual reality simulators and ex vivo tissue models now replicate the tactile nuances of tissue dissection, allowing trainees to refine hand-eye coordination and complication management in a risk-free environment. Moreover, cross-institutional mentorship networks and teleproctoring platforms have democratized access to expert guidance, accelerating proficiency in regions previously limited by resource constraints. As a result, procedural adoption curves are flattening, and the global clinician community is advancing toward standardized ESD curricula anchored in rigorous outcome metrics. Collectively, these shifts underscore a patient-centered ethos that prioritizes safety, efficiency, and equitable access as the cornerstones of the next generation of GI therapeutic endoscopy.

Implications of 2025 U.S. Tariff Adjustments on Device Procurement and Clinical Accessibility

In 2025, the United States enacted a series of tariff modifications targeting imported medical devices and accessory components integral to endoscopic submucosal dissection. These adjustments have introduced nuanced cost pressures across the supply chain, particularly for advanced electrosurgical knives, specialized insufflation units, and high-definition endoscopes. Hospitals and outpatient centers are assessing strategic pivots in procurement practices, including supplier diversification and proactive contract renegotiations to mitigate the impact of increased landed costs. Concurrently, manufacturers are reevaluating supply chain configurations, exploring nearshoring opportunities, and optimizing component sourcing to preserve competitive pricing and maintain clinician access to state-of-the-art equipment.

Beyond immediate cost considerations, the tariff landscape is influencing broader research and development priorities. Device innovators are accelerating the design of modular systems that utilize locally sourced components and refining manufacturing processes to reduce dependency on tariff-affected imports. Health systems are likewise undertaking comprehensive budget impact analyses to balance capital expenditures against long-term clinical benefits, with an emphasis on value-based procurement policies. These strategic responses are reshaping the interplay between cost containment and clinical innovation, ultimately defining new benchmarks for market resilience and operational agility in the ESD space.

Strategic Dissection of Market Segmentation by Product Innovations, Procedural Variants, Clinical Indications, Pathological Classifications, and Channel Engagement

The endoscopic submucosal dissection market can be deconstructed by examining product innovations across accessory devices and core endoscopy systems. Accessory devices encompass items such as cap and hood assemblies, forceps and clips, injection needles, insufflation units, various knife subtypes, and trocars. Within the knife category itself, dual, flex, hook, insulation-tipped, and triangle-tipped instruments delineate performance attributes tailored to specific tissue textures and lesion topographies. Endoscopy systems further subdivide into colonoscopes, duodenoscopes, and gastroscopes, each embodying unique ergonomic and optical configurations that influence procedural efficiency and clinician preference.

Procedural modalities range from full-thickness resection techniques that enable complete transmural excision to hybrid approaches that integrate submucosal tunneling with en bloc removal, as well as partial-thickness resections optimized for discrete lesions. These variants have demonstrated varying risk-benefit profiles, informing institutional adoption based on tumor characteristics and operator proficiency. Clinical indications driving ESD adoption include colorectal, esophageal, and gastric cancer, reflecting the epidemiological burden of early-stage neoplastic presentations. Parallel to indication-based segmentation is the classification by disease condition, distinguishing benign tumors from malignant tumors and further stratifying malignant cases into invasive and non-invasive categories. This granularity informs both technology utilization and outcome expectations.

Finally, end-user channels span ambulatory surgical centers, hospitals, and specialty clinics, each presenting distinct procedural volumes, reimbursement frameworks, and investment capacities. Ambulatory surgical centers are gaining traction as efficient venues for straightforward ESD procedures, while tertiary hospitals continue to anchor complex cases and training initiatives. Specialty clinics focused on advanced endoscopy further contribute to the diffusion of technique-specific expertise and high-acuity patient management.

Illuminating Regional Adoption Patterns, Reimbursement Frameworks, and Innovation Trajectories Across Global Markets

In the Americas, robust healthcare infrastructures and well-established reimbursement systems underpin a strong base for endoscopic submucosal dissection adoption. Centers of excellence across the United States and Canada lead in procedural volumes and publish pivotal clinical evidence, reinforcing stakeholder confidence. Policy environments that support advanced endoscopic interventions have enabled payers to recognize the long-term cost savings associated with minimally invasive lesion removal, thereby fostering patient access and institutional investment in cutting-edge devices.

Across Europe, the Middle East, and Africa, regulatory heterogeneity and varying reimbursement pathways create a mosaic of adoption rates. Western European nations with centralized health technology assessment processes have integrated ESD into standard care protocols for indicated lesions, whereas emerging markets within the region are actively building clinical infrastructure and training networks to bridge gaps in procedural expertise. Meanwhile, several Middle Eastern health systems are accelerating capital investments in specialized endoscopy units to position their centers at the forefront of GI oncology treatment.

The Asia-Pacific region continues to be a global leader in procedural innovation and clinical evidence generation, driven by high patient volumes and proactive government initiatives. Countries such as Japan and South Korea remain pioneers in technique refinement, while rapidly developing economies like India and China are scaling training programs and local device manufacturing capacities. Collaborative research consortia and public-private partnerships in the region are further expediting technology transfer and establishing new benchmarks for affordability and access.

Competitive Landscape and Strategic Movements of Leading Stakeholders Shaping the ESD Ecosystem

A cadre of global medtech leaders and specialized innovators defines the competitive contours of the endoscopic submucosal dissection market. Established incumbents are reinforcing their portfolios through incremental product enhancements, securing intellectual property for advanced knife geometries and ergonomic scope designs, and leveraging global distribution networks to broaden market penetration. Simultaneously, agile startups are gaining traction by introducing AI-assisted lesion detection software and next-generation insufflation technologies aimed at streamlining procedural workflows.

Strategic partnerships and collaborations between device manufacturers, academic centers, and contract research organizations have accelerated clinical validation pathways and enhanced regulatory readiness. Moreover, mergers and acquisitions remain a focal strategy for integrating complementary technologies and fortifying intellectual property pipelines. As these developments unfold, leading stakeholders are also prioritizing lifecycle management programs that include reusable component sterilization solutions, subscription-based service models, and digital health platforms designed to monitor post-procedural outcomes.

Overall, the competitive landscape is characterized by a dual imperative: advancing clinical performance while optimizing total cost of ownership. Organizations that successfully align product innovation, service excellence, and data-driven customer support are best positioned to capture value in an increasingly sophisticated ESD environment.

Proactive Strategies and Collaborative Initiatives to Propel Innovation, Market Penetration, and Sustainable Growth

To capitalize on the burgeoning opportunities in endoscopic submucosal dissection, industry leaders must emphasize cross-functional partnerships that bridge clinical, regulatory, and commercial expertise. Prioritizing investment in R&D for next-generation electrosurgical knives with adaptive feedback mechanisms will differentiate product offerings and address evolving clinical challenges. Concurrently, establishing comprehensive training ecosystems that integrate virtual reality simulators and certified proctorship ensures consistent procedural quality and shortens adoption curves for emerging markets.

Engaging with payers and health authorities to demonstrate the value proposition of ESD through real-world evidence and cost-effectiveness analyses will facilitate favorable reimbursement decisions and expand patient access. Diversifying supply chain networks by incorporating regional manufacturing hubs and strategic sourcing initiatives can mitigate tariff-related risks while optimizing inventory turnover. Furthermore, developing digital platforms for perioperative patient engagement and outcome tracking will foster data-driven improvements in clinical protocols and strengthen long-term customer loyalty.

Ultimately, aligning these strategies with sustainable business models-such as service-based agreements and outcome-based reimbursement schemes-will enhance market resilience. By adopting a holistic approach that balances innovation, education, and stakeholder alignment, organizations can secure a leadership position in the evolving ESD ecosystem.

Rigorous Multimodal Research Framework Integrating Primary Inquiry, Secondary Data, and Analytical Triangulation

The research underpinning this executive summary was conducted through a meticulous blend of primary and secondary methodologies. Key opinion leaders and endoscopy specialists were engaged in structured interviews and advisory workshops to capture nuanced perspectives on clinical workflows, technology adoption barriers, and unmet needs in endoscopic submucosal dissection. These qualitative insights were complemented by an extensive review of peer-reviewed journals, clinical trial registries, and conference proceedings to validate evolving best practices and emergent device performance data.

Secondary research included systematic analysis of regulatory filings, patent landscapes, and financial disclosures to map innovation trajectories and competitive positioning. Additionally, a detailed assessment of tariff schedules, reimbursement codes, and health technology assessment reports informed the evaluation of macroeconomic drivers. Quantitative data points were then subjected to triangulation against real-world procedural volumes and market intelligence sources to ensure consistency and reliability. The final deliverables underwent multiple iterations of peer review and methodological audits to confirm the integrity of findings and recommendations.

Synthesis of Core Insights and Future Trajectories to Empower Decision Makers and Foster Market Leadership

This executive summary has elucidated the intricate interplay of technological innovation, regulatory shifts, and market dynamics shaping the endoscopic submucosal dissection domain. Key takeaways underscore the critical impact of advanced knife designs, enhanced imaging modalities, and AI-driven decision support tools on procedural efficacy and safety. Simultaneously, the ramifications of tariff adjustments and evolving reimbursement landscapes necessitate agile sourcing strategies and proactive stakeholder engagement.

Looking ahead, the maturation of competency-based training programs, cross-border collaborations, and localized manufacturing initiatives will accelerate diffusion in underpenetrated markets. The integration of digital health platforms for patient monitoring and outcome analytics promises to refine clinical protocols and bolster evidence generation. As industry leaders align on sustainable business models and engage payers with compelling value narratives, endoscopic submucosal dissection is poised to become a standardized cornerstone of early gastrointestinal cancer management. Decision makers equipped with these insights are well-positioned to navigate complexity, drive innovation, and deliver superior patient outcomes.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Endoscopic Submucosal Dissection Market, by Product

  • 8.1. Accessory Devices
    • 8.1.1. Cap & Hood
    • 8.1.2. Forceps & Clips
    • 8.1.3. Injection Needles
    • 8.1.4. Insufflations Units
    • 8.1.5. Knives
      • 8.1.5.1. Dual
      • 8.1.5.2. Flex
      • 8.1.5.3. Hook
      • 8.1.5.4. Insulation-tipped
      • 8.1.5.5. Triangle-tipped
    • 8.1.6. Trocars
  • 8.2. Endoscopy Devices
    • 8.2.1. Colonoscopes
    • 8.2.2. Duodenoscopes
    • 8.2.3. Gastroscopes

9. Endoscopic Submucosal Dissection Market, by Procedure Type

  • 9.1. Full-Thickness Resection
  • 9.2. Hybrid ESD
  • 9.3. Partial-Thickness Resection

10. Endoscopic Submucosal Dissection Market, by Indication Type

  • 10.1. Colorectal Cancer
  • 10.2. Esophageal Cancer
  • 10.3. Gastric Cancer

11. Endoscopic Submucosal Dissection Market, by Disease Condition

  • 11.1. Benign Tumors
  • 11.2. Malignant Tumors
    • 11.2.1. Invasive
    • 11.2.2. Non-Invasive

12. Endoscopic Submucosal Dissection Market, by End-User Type

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. Endoscopic Submucosal Dissection Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Endoscopic Submucosal Dissection Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Endoscopic Submucosal Dissection Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Endoscopic Submucosal Dissection Market

17. China Endoscopic Submucosal Dissection Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Ambu A/S
  • 18.6. Beijing ZKSK Technology Co., Ltd.
  • 18.7. Boston Scientific Corporation
  • 18.8. ConMed Corporation
  • 18.9. Erbe Elektromedizin GmbH
  • 18.10. Fujifilm Holdings Corporation
  • 18.11. Hoya Corporation
  • 18.12. Huger Medical Instrument Co., Ltd.
  • 18.13. Interscope, Inc.
  • 18.14. Jiangsu Vedkang Medical Science and Technology Co., Ltd.
  • 18.15. Karl Storz SE & Co. KG
  • 18.16. Leo Medical Co. Ltd.
  • 18.17. Medi-Globe GmbH by DCC Healthcare
  • 18.18. Medtronic PLC
  • 18.19. Micro-Tech Endoscopy
  • 18.20. Mizuho America, Inc.
  • 18.21. MTW-Endoskopie W. Haag KG
  • 18.22. Olympus Corporation
  • 18.23. Ovesco Endoscope AG
  • 18.24. Richard Wolf GmbH
  • 18.25. SonoScape Medical Corp.
  • 18.26. Steris Corporation
  • 18.27. Sumitomo Bakelite Co., Ltd.
  • 18.28. Zeon Medical Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY CAP & HOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FORCEPS & CLIPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INJECTION NEEDLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSUFFLATIONS UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FLEX, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOOK, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INSULATION-TIPPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TRIANGLE-TIPPED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY TROCARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLONOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DUODENOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTROSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY FULL-THICKNESS RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HYBRID ESD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PARTIAL-THICKNESS RESECTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COLORECTAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ESOPHAGEAL CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GASTRIC CANCER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY BENIGN TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY NON-INVASIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 128. LATIN AMERICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 156. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 157. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 158. MIDDLE EAST ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 165. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 167. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 168. AFRICA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 175. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 177. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 178. ASIA-PACIFIC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 184. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 188. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 189. ASEAN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 191. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 192. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 193. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 194. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 195. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 198. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 199. GCC ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 202. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 204. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 205. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 208. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 209. EUROPEAN UNION ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 210. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 212. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 213. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 214. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 215. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 218. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 219. BRICS ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 222. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 223. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 224. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 225. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 228. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 229. G7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 232. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 233. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 234. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 237. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 238. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 239. NATO ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 241. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 242. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 243. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 244. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 245. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 246. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 247. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 249. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 250. UNITED STATES ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 252. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 253. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ACCESSORY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 254. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY KNIVES, 2018-2032 (USD MILLION)
  • TABLE 255. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY ENDOSCOPY DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 257. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY INDICATION TYPE, 2018-2032 (USD MILLION)
  • TABLE 258. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY DISEASE CONDITION, 2018-2032 (USD MILLION)
  • TABLE 259. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY MALIGNANT TUMORS, 2018-2032 (USD MILLION)
  • TABLE 260. CHINA ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SIZE, BY END-USER TYPE, 2018-2032 (USD MILLION)